Category: INO.com Contributors

Silver Has Hit The Target And Marked A New One!

Posted on by Aibek Burabayev

Aibek Burabayev - INO.com Contributor - Metals


Silver has overshot the target set at the $20 mark in my June post leaving the gold in the dust. The AB/CD concept is simple yet effective as it utilizes perpetual Fibonacci ratios.

Ok, that’s done, but what is next? Let’s look at the charts below. I put the monthly chart first to refresh the global outlook for the soaring metal.

Chart 1. Silver Monthly: The Game Just Started!

Monthly Chart of Silver
Chart courtesy of tradingview.com

The metal has finally shot above the black downtrend, which I was talking about in my March update. It was a vital need for silver to break loose from the multi-year grip to stop the drop. Continue reading "Silver Has Hit The Target And Marked A New One!" →

How To Profit From Brexit - Guaranteed!

Posted on by George Yacik

George Yacik - INO.com Contributor - Fed & Interest Rates


With interest rates plunging all over the world, including right here in the U.S., many fixed-income investors are scratching their heads about where they can find something that pays more than 1% without taking on a pile of risk.

The answer is right under their noses. Plus, the return is way better than you can get on stocks and bonds (even gold!). Not only that, but the return is guaranteed.

What is this magic investment? Continue reading "How To Profit From Brexit - Guaranteed!" →

IBB: Brexit Collateral Damage Provides Brief Buying Opportunity

Posted on by Noah Kiedrowski

Noah Kiedrowski - INO.com Contributor - Biotech


As Brexit wreaked havoc on international financial markets, it presented a brief opportunity to capitalize on the collateral damage fallout within the biotechnology cohort. This event may continue to offer entry points as the reverberations are felt throughout the markets. I didn’t factor in the possibility that a major economic power within the EU would vote to relinquish its membership and move forward as an independent nation. However as Brexit became reality, I utilized this opportunity to deploy capital in the biotechnology cohort via the iShares Biotechnology Index ETF (NASDAQ:IBB) as a long-term investor within the space. As the UK proceeded with its divorce from the EU, markets sold off in a meaningful way. Brexit introduced instability throughout the region thus negatively impacting financial markets abroad. I largely view the Brexit as an extraneous event unrelated directly to the biotechnology cohort; thus I utilized this brief opportunity to add to my position in IBB and may continue to add in periods of weakness. Continue reading "IBB: Brexit Collateral Damage Provides Brief Buying Opportunity" →

Natural Gas Prices Surging With Dog Days Of Summer Ahead

Posted on by Robert Boslego

Robert Boslego - INO.com Contributor - Energies


Chart of Natural Gas Futures Prices

Natural gas futures prices have risen almost 80-percent from their lows in March, with much of the gain occurring over the past month. Based on my analysis of the Commitments of Traders (COT) reports, issued by the Commodity Futures Trading Commission (CFTC), the vast majority of the buying that propelled prices came from short speculators who covered (bought) to limit further losses. Since early March, they had purchased more than 100,000 futures and options contracts (see graph below). Continue reading "Natural Gas Prices Surging With Dog Days Of Summer Ahead" →

Pick Almost Flat For Year, But Has Room To Move

Posted on by admin

INO.com's Stock of the Week

It's been 6 hours since our Stock of the Week subscribers received our latest pick. Before the opening bell, we sent the full analysis for this hand-picked stock to the inboxes of those who have requested this complimentary resource.

Send me this week's stock.

This week's pick is a solid growth story that should continue to move forward regardless of what happens to the economy in the short term. The stock trades in line with its competitors, but comes with a relatively high long-term growth rate of 7% for a company valued at more than $210 billion.

Perhaps the biggest selling point for investors though is the stock's defensive capabilities. It has proven to be a great investment no matter the market conditions. When times are great, people buy this company's products. When times are tough, people buy this company's products.

Right now our analyst, Daniel Cross, believes that this stock can offer a 14% return based on the current valuation and the stock's dividend yield.

Want to know what this stock is?

If you're already a subscriber, please check your inbox. If you are not, just request the Stock of the Week here.

You'll receive a new pick from our analyst, Daniel Cross, every Tuesday before the opening bell.

Enjoy,
INO.com & Daniel Cross


su*****@in*.com